The cell processing market involves a series of complex procedures including isolation, separation, purification, vitrification and thawing of cells. Cell processing finds wide applications in regenerative medicine, cancer research, biological studies and IVF. Technological advancements in cell processing systems have provided consistent, robust and reproducible workflow for cell analysis and isolation. The growing geriatric population, increasing prevalence of infertility and rising awareness about egg freezing are some of the key factors boosting the demand for IVF treatments over the years. As cell processing plays a crucial role in IVF success rates, the growth of IVF industry acts as a major driver for this market.
The Global cell processing market is estimated to be valued at US$ 1.93 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the cell processing are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, Welling Home Health.
The key opportunities in the Cell Processing Market Growth include technological advancements in cell isolation techniques, growing research activities in regenerative medicines and increasing public-private investments. As per estimates, the global spending on regenerative medicine is projected to reach $24.3 billion by 2025 from $11.8 billion in 2019 indicating significant growth opportunities.
North America dominates the global cell processing market due to high healthcare spending, availability of advanced healthcare facilities and presence of major industry players in the region. However, Asia Pacific is expected to witness highest growth during the forecast period supported by growing infertility rates, increasing medical tourism and expanding healthcare infrastructure in emerging countries.
Market Drivers
The major market driver is the rising number of IVF procedures globally. As per estimates, over 8 million babies have been born worldwide using IVF technology till date. Other key drivers include increasing cases of cancer warranting cell therapies, growing geriatric population prone to chronic diseases and rising investments in regenerative medicine research. The significant cost and time reduction associated with cell processing automation is also fueling the adoption of advanced cell processing systems.
PEST Analysis
Political: The regulation surrounding Cell Processing Market Analysis and therapy is increasing across regions to ensure standards and safety are met. Regulations help standardize practices and monitor new treatments.
Economic: The global economy is recovering post pandemic which is boosting healthcare spending and investments in new cell therapies. Cell processing market is projected to grow at a high CAGR supported by increasing research funding and commercialization of novel therapies.
Social: The acceptance of new cell therapies is increasing driven by rising population awareness. Cell therapies offer hope for previously untreatable conditions generating social interest. Ethical debates around some applications need oversight.
Technological: Advanced technologies like automated closed systems, microfluidics and analytics are improving cell processing workflows. Novel culture media and isolation techniques enhance yields. Integration of technologies enables real-time processing and quality control critical for personalized therapies.
Geographical regions with high market concentration
North America accounts for the largest share of the global cell processing market by value. This is attributed to presence of major players, rising healthcare investments, and fast regulatory approvals. High healthcare expenditure per capita in the US and Canada supplements market growth.
Asia Pacific is the fastest growing regional market for cell processing. This growth can be attributed to rising healthcare infrastructure, booming biotech industry and increasing medical tourism in countries like China, India, Singapore and South Korea. Growing population, rising incomes and awareness are driving preventive healthcare and contributing to regional market expansion.
Get more insights on Cell Processing Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
0 comment